• Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
Top Trading Strategy
No Result
View All Result
Home Breaking News

J&J plans to split into two companies, separating consumer products and pharmaceutical businesses

by
November 12, 2021
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Health-care conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its pharmaceutical and medical device operations, creating two publicly traded companies. The news sent shares higher in premarket trading.

Related Posts

Disney needs to show investors it has a plan to make streaming profitable — and stop hemorrhaging money

Bitcoin trades around $23,000 after Fed Chair Powell warns that rates could rise further

Zoom to lay off 1,300 employees, or about 15% of its workforce

Goldman says these overlooked companies play a key role in a more sustainable economy

The separation will sheer off its household products unit, maker of Band-Aid bandages, Aveeno and Neutrogena skin care products and Listerine, from its riskier, but faster-growing division that makes and sells prescription drugs and medical devices, including its Covid-19 vaccine.

“Following a comprehensive review, the board and management team believe that the planned separation of the consumer health business is the best way to accelerate our efforts to serve patients, consumers, and healthcare professionals, create opportunities for our talented global team, drive profitable growth, and – most importantly – improve healthcare outcomes for people around the world,” outgoing CEO Alex Gorsky said in a statement.

The company said it hopes to complete the transaction in 18 to 24 months. The pharmaceutical and medical device division, which includes advanced technologies like robotics and AI, would retain the name Johnson & Johnson and have J&J’s incoming CEO Joaquin Duato at its helm.

Duato is taking over the role in January as previously planned. Those segments are expected to generate roughly $77 billion in revenue while the consumer products division is forecast to sell about $15 billion in products this year, the company said.

Its yet-to-be-named consumer products company will also inherit litigation stemming from lawsuits over claims that its Johnson’s Baby Powder causes cancer, allegations the company has vehemently denied.

Shares of J&J were up more than 3% in premarket trading after the announcement.

J&J was already undergoing a major transition with Gorsky’s departure as CEO. He will remain on as executive chairman of the new J&J, the company said.

Additionally, the company said it planned to keep its total dividend “at least at the same level” following the change. J&J currently sports a dividend yield of about 2.6%.

The announcement comes just days after General Electric said it plans to split into three separate companies, spinning out its medical unit from its aviation and energy units.

Next Post

Black Knight: Number of Mortgages in Forbearance Declines

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Popular Posts

Breaking News

Disney needs to show investors it has a plan to make streaming profitable — and stop hemorrhaging money

by
February 7, 2023
0

When Walt Disney (DIS) reports fiscal first-quarter earnings on Wednesday, we'll be looking to see how the entertainment giant plans...

Read more

Disney needs to show investors it has a plan to make streaming profitable — and stop hemorrhaging money

Bitcoin trades around $23,000 after Fed Chair Powell warns that rates could rise further

Zoom to lay off 1,300 employees, or about 15% of its workforce

Goldman says these overlooked companies play a key role in a more sustainable economy

Inflation Reduction Act has spurred 100,000 new green jobs so far: Here’s where they are

Fed Chair Powell says inflation is starting to ease, but interest rates still likely to rise

Load More

All rights reserved by www.toptradingstrategy.net

  • Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
  • Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.